Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kentaro Ito

Showing results (61-70 of 164) with videos related to

Pageof 17
Sort By:
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
The impact of high PD-L1 expression on the surrogate endpoints and clinical outcomes of anti-PD-1/PD-L1 antibodies in non-small cell lung cancerKentaro Ito, Satoru Miura, Tadashi Sakaguchi, et al.
Thoracic Cancer|May 18, 2021
Assessment of chemotherapy regimens on radiation pneumonitis in patients with unresectable stage III non-small-cell lung cancer after definitive chemoradiotherapyTadashi Sakaguchi, Kentaro Ito, Naoki Furuya, et al.
International Journal of Molecular Sciences|February 26, 2022
Cytoskeletal Protein 4.1G Is Essential for the Primary Ciliogenesis and Osteoblast Differentiation in Bone FormationMasaki Saito, Marina Hirano, Tomohiro Izumi, et al.
Therapeutic Advances in Medical Oncology|January 6, 2021
Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysisHao Chen, Nobuyuki Horita, Kentaro Ito, et al.
Thoracic Cancer|January 15, 2021
Real-world efficacy of atezolizumab in non-small cell lung cancer: A multicenter cohort study focused on performance status and retreatment after failure of anti-PD-1 antibodyNaoki Furuya, Makoto Nishino, Kazushige Wakuda, et al.
Thoracic Cancer|April 16, 2020
The efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non-small cell lung cancerTadashi Sakaguchi, Naoki Furuya, Kentaro Ito, et al.
Cancer Science|April 2, 2008
Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complexTakashi Miyasaka, Masahiro Morita, Kentaro Ito, et al.
The American Journal of Case Reports|July 30, 2022
Atypical Splenic Abscesses Due to Clostridioides difficileYukiko Komeno, Takeru Iida, Ayumu Kocha, et al.
Internal Medicine (Tokyo, Japan)|April 23, 2026
Azathioprine withdrawal leading to spontaneous remission of Iatrogenic Epstein-Barr virus-negative diffuse large B-cell lymphoma: A case report and literature reviewHajime Yasuda, Sakiko Harada, Mayu Matsushita, et al.
Gastroenterology Report|July 8, 2026
Feasibility and tolerability of reduced-volume oral sulfate solution combined with elobixibat for bowel preparation before colonoscopy: a single-center pilot studyTakashi Murakami, Kentaro Ito, Eiji Kamba, et al.
Pageof 17

Showing results (61-70 of 164) with videos related to

Sort By:
Pageof 17
Lung Cancer (Amsterdam, Netherlands)|January 16, 2019
The impact of high PD-L1 expression on the surrogate endpoints and clinical outcomes of anti-PD-1/PD-L1 antibodies in non-small cell lung cancerKentaro Ito, Satoru Miura, Tadashi Sakaguchi, et al.
Thoracic Cancer|May 18, 2021
Assessment of chemotherapy regimens on radiation pneumonitis in patients with unresectable stage III non-small-cell lung cancer after definitive chemoradiotherapyTadashi Sakaguchi, Kentaro Ito, Naoki Furuya, et al.
International Journal of Molecular Sciences|February 26, 2022
Cytoskeletal Protein 4.1G Is Essential for the Primary Ciliogenesis and Osteoblast Differentiation in Bone FormationMasaki Saito, Marina Hirano, Tomohiro Izumi, et al.
Therapeutic Advances in Medical Oncology|January 6, 2021
Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysisHao Chen, Nobuyuki Horita, Kentaro Ito, et al.
Thoracic Cancer|January 15, 2021
Real-world efficacy of atezolizumab in non-small cell lung cancer: A multicenter cohort study focused on performance status and retreatment after failure of anti-PD-1 antibodyNaoki Furuya, Makoto Nishino, Kazushige Wakuda, et al.
Thoracic Cancer|April 16, 2020
The efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non-small cell lung cancerTadashi Sakaguchi, Naoki Furuya, Kentaro Ito, et al.
Cancer Science|April 2, 2008
Interaction of antiproliferative protein Tob with the CCR4-NOT deadenylase complexTakashi Miyasaka, Masahiro Morita, Kentaro Ito, et al.
The American Journal of Case Reports|July 30, 2022
Atypical Splenic Abscesses Due to Clostridioides difficileYukiko Komeno, Takeru Iida, Ayumu Kocha, et al.
Internal Medicine (Tokyo, Japan)|April 23, 2026
Azathioprine withdrawal leading to spontaneous remission of Iatrogenic Epstein-Barr virus-negative diffuse large B-cell lymphoma: A case report and literature reviewHajime Yasuda, Sakiko Harada, Mayu Matsushita, et al.
Gastroenterology Report|July 8, 2026
Feasibility and tolerability of reduced-volume oral sulfate solution combined with elobixibat for bowel preparation before colonoscopy: a single-center pilot studyTakashi Murakami, Kentaro Ito, Eiji Kamba, et al.
Pageof 17